knowledge -WSS

knowledge

author：entertainment 2025-09-28 19:25:34 - browse：6877

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： The history of OxyContin, told through Purdue Pharma documents

leisure time

WSS

Researchers on aging grapple with how to calculate biological age

The perfect storm of weather conditions that led to the devastating wildfires in Maui

White House drug shortages task force keeps mum with Congress

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Making AI in medicine accessible to smaller, and rural hospitals

Wikipedia

knowledge

entertainment

Medical records are filled with copy

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Bright Health sells Medicare Advantage business to Molina

Pharma budget tightening trickles down to Doximity

Heart attack and stroke risk calculators need revising

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Anesthesiologist group: stop taking Ozempic before surgery

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Medicare proposal to cover medical devices draws a mixed reaction

Google says AlphaFold 3 can map a vast universe of biomolecules

focus

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

H5N1 bird flu: what we're starting to learn about infection in cows

Timeline: Special counsel's investigation into Trump's handling of classified documents

Study: People of West African ancestry at greater risk of cardiac amyloidosis

After gene therapy, two congenitally deaf children hear for the first time

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

leisure time

entertainment

focus

hotspot